The Roundup – February 13, 2025

: Monday, March 10
: 2:00pm – 4:30pm, Reception to follow
: The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT

Opening Comments     
Jodie Gillon, President & CEO, BioCT
Welcome   
Lon Cardon, Ph.D., FMedSci, President and CEO, The Jackson Laboratory
Featured Speaker   
Cat Lutz, Ph.D., Vice President, Rare Disease Translational Center, The Jackson Laboratory

Panel: Innovation in Discovery & Translation: Importance of Genomics, Data Sciences and Diagnostics for Rare Disease Therapeutics Innovation  
Moderator:
Mark Adams, Ph.D., Interim Scientific Director & Professor, The Jackson Laboratory      
Panelists:
Angela Cacace, Ph.D., CSO, Arvinas
Tom DeFay, Ph.D., Deputy Head of Diagnostics Strategy & Development at Alexion; Vice-Chair of the BeginNGS Newborn Sequencing Consortium
Birgit Fogal, Ph.D., Interim Vice President, Nonclinical Drug Safety US; Director, Nonclinical Drug Safety Strategies, Boehringer Ingelheim
Rebecca Riba-Wolman, M.D., Director of the Glycogen Storage Disease Program & Disorders of Hypoglycemia, Connecticut Children’s Hospital; Associate Professor, University of Connecticut Medical School
Topics: Clinical and Preclinical Data, Biomarkers and Models: Genes to translation pipeline, AI applications in patient identification and diagnostics. Importance of Genomics, Data Sciences and Diagnostics for rare disease therapeutics innovation

Panel: Bringing Science to the Patient: Moving Upstream Toward Durable Response and Cures
Moderator:
Jodie Gillon, President & CEO, BioCT
Panelists:
Michael Aberman, M.D., General Partner, Regeneron Ventures
Monica Coenraads, CEO, Founder of Rett Syndrome Research Trust
Pam Gavin, CEO, National Organization for Rare Disorders (NORD)
Nick Vita, CEO, Co-Founder and Chairman of Apriligen, Inc.
Topics: Therapeutics Innovation: Moving upstream towards durable response and cures. Sponsors and investors, regulatory and patient delivery

Closing Remarks 
Reception

Don’t delay. Register here.
Patients, advocates and legislators are invited to attend at no charge.
​Note: Registration closes March 7, 11:59pm EST. All attendees must register in advance.

Limited sponsorship opportunities are currently availabe: 2 Table Sponsorships and 1 Video Sponsorship. Act today. Details here.

Join us at NOLO for this month’s Collaborative CT, the go-to networking event that brings together Connecticut’s innovation community. Cash bar and tasty New Haven apizza and salad, courtesy of amplifyHERscience.

Join the American Cancer Society Cancer Action Network on March 19 at the Capitol for 2025 Connecticut Cancer Action Day! Together cancer survivors, caregivers, and advocates will meet with lawmakers urging them to support legislation that will help Connecticut cancer patients receive the care they need and deserve. For more information, click here.

Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital. Learn more information and apply here.

SPONSORSHIPS AVAILABLE: Connecticut Pavillon at BIO 2025 – Booth #1265

A delegation of Connecticut partners will return to BIO 2025 to exhibit our growing life sciences industry to a global audience.

The Connecticut Pavilion will feature sponsor branding and serve as the central hub for hosting clients and holding meetings. The Pavilion will also be the site of networking receptions and strategic marketing efforts to draw additional traffic and attention to the state and pavilion sponsors. For more information on sponsorship and attendance opportunities, click here, or contact Kelley Gipson at kgipson@bioct.org.